People living with human immunodeficiency virus (PLHIV) have excess risk of
atherosclerotic cardiovascular disease (ASCVD). Arterial inflammation is the hallmark of …

Background Persistent vascular inflammation has been implicated as an important cause for
a higher prevalence of cardiovascular disease (CVD) in HIV-infected adults. In several …

People living with human immunodeficiency virus (HIV) infection have twice the risk of
atherosclerotic vascular disease compared with non-infected individuals. Inflammation plays …

Background HIV-infected patients are at increased risk of myocardial infarction and arterial
inflammation has been suggested as a pathophysiological explanation. We compared the …

CXC motif chemokine receptor 4 (CXCR4) is expressed on the surface of various cell types
involved in atherosclerosis, with a particularly rich receptor expression on macrophages and …

Abstract Study Design To compare arterial inflammation (AI) between people living with HIV
(PLWH) and uninfected people as assessed by 18 F-Fluorodeoxyglucose (18 F-FDG) …

Background and aims Molecular imaging with 18 Fluorodeoxyglucose (FDG) and 18 F-
sodium-fluoride (NaF) captures arterial inflammation and micro-calcification and can reveal …

68Ga-pentixafor is a radiotracer for PET that binds with nanomolar affinity to CXCR4. The
CXCR4 receptor is expressed at the surface of inflammatory cells. The objective of the study …

Context Cardiovascular disease is increased in patients with human immunodeficiency virus
(HIV), but the specific mechanisms are unknown. Objective To assess arterial wall …

The CXC-motif chemokine receptor 4 (CXCR4) represents a promising target for molecular
imaging of different CXCR4-positive cell types in cardiovascular diseases such as …